Jiang Zhong Pharmaceutical Co.,Ltd

Shanghai Stock Exchange 600750.SS

Jiang Zhong Pharmaceutical Co.,Ltd Gross Profit Margin for the year ending December 31, 2023: 65.31%

Jiang Zhong Pharmaceutical Co.,Ltd Gross Profit Margin is 65.31% for the year ending December 31, 2023, a 0.72% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Jiang Zhong Pharmaceutical Co.,Ltd Gross Profit Margin for the year ending December 31, 2022 was 64.84%, a 0.78% change year over year.
Jiang Zhong Pharmaceutical Co.,Ltd Gross Profit Margin for the year ending December 31, 2021 was 64.34%, a -1.57% change year over year.
Jiang Zhong Pharmaceutical Co.,Ltd Gross Profit Margin for the year ending December 31, 2020 was 65.37%, a -1.93% change year over year.
Jiang Zhong Pharmaceutical Co.,Ltd Gross Profit Margin for the year ending December 31, 2019 was 66.66%, a -1.18% change year over year.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

Shanghai Stock Exchange: 600750.SS

Jiang Zhong Pharmaceutical Co.,Ltd

CEO	Mr. Wenbin Xiao
IPO Date	Sept. 23, 1996
Location	China
Headquarters	No. 788 Torch Street
Employees	4,013
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Jiang Zhong Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of traditional Chinese medicine and health foods. The company offers OTC class products for gastrointestinal digestion, upper respiratory tract, and tonics; protein nutrition, tonics, health regimen, probiotics, daily protection, beauty, bone health, and plant liver protection health products; and prescription products. It sells its products under the Jiangzhong and Jianweixiaoshi brands. Jiang Zhong Pharmaceutical Co.,Ltd is based in Nanchang, China.

Key trends

Past 5 years